Literature DB >> 1702631

Affinity enhancement of bispecific antibody against two different epitopes in the same antigen.

H S Cheong1, J S Chang, J M Park, S M Byun.   

Abstract

For the enhancement of antibody binding affinity, a bispecific antibody against two different epitopes in human chorionic gonadotropin hormone, one is in alpha-subunit and the other is in beta-subunit, was prepared by chemical recombination using 5,5'-dithiobis(2-nitrobenzoic acid). The epitopes recognized by antibodies were investigated by competitive radioimmunoassay, two-site sandwich radioimmunoassay and additivity assay and a proper epitope pair was chosen for preparation of the bispecific antibody. This bispecific antibody has dual specificity and as much as 17.2-fold higher affinity than that of monoclonal antibody with higher affinity by dual antigen binding radioimmunoassay and Scatchard plot analysis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702631     DOI: 10.1016/s0006-291x(05)80857-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells.

Authors:  Emily C Piccione; Silvia Juarez; Jie Liu; Serena Tseng; Christine E Ryan; Cyndhavi Narayanan; Lijuan Wang; Kipp Weiskopf; Ravindra Majeti
Journal:  MAbs       Date:  2015       Impact factor: 5.857

2.  Enhancement in antigen binding by a combination of synergy and antibody capture.

Authors:  T Klonisch; G Panayotou; P Edwards; A M Jackson; P Berger; P J Delves; T Lund; I M Roitt
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

3.  A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity.

Authors:  Wenlong Tan; Yanchun Meng; Hui Li; Yang Chen; Siqi Han; Jing Zeng; Ang Huang; Bohua Li; Yanyun Zhang; Yajun Guo
Journal:  MAbs       Date:  2013 Nov-Dec       Impact factor: 5.857

4.  Expeditious Generation of Biparatopic Common Light Chain Antibodies via Chicken Immunization and Yeast Display Screening.

Authors:  Jan P Bogen; Stefania C Carrara; David Fiebig; Julius Grzeschik; Björn Hock; Harald Kolmar
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561

Review 5.  Development of Bispecific Antibody for Cancer Immunotherapy: Focus on T Cell Engaging Antibody.

Authors:  Dain Moon; Nara Tae; Yunji Park; Seung-Woo Lee; Dae Hee Kim
Journal:  Immune Netw       Date:  2022-02-14       Impact factor: 5.851

Review 6.  CD47-SIRPα blocking-based immunotherapy: Current and prospective therapeutic strategies.

Authors:  Renée Bouwstra; Tom van Meerten; Edwin Bremer
Journal:  Clin Transl Med       Date:  2022-08

7.  A unique bivalent binding and inhibition mechanism by the yatapoxvirus interleukin 18 binding protein.

Authors:  Brian Krumm; Xiangzhi Meng; Zhixin Wang; Yan Xiang; Junpeng Deng
Journal:  PLoS Pathog       Date:  2012-08-23       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.